Swarajya

Our View
MagazineHeadlinesVideosस्वराज्यBooksEconomyCultureAdvertise
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economy
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • Weekend Issues Archive
  • News Brief
  • Subscriber login
  • Politics
  • Economy
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • Weekend Issues Archive
  • News Brief

oxford-AstraZeneca

Data: Where  States Stand In The Covid-19 Vaccination Drive
Data: Where States Stand In The Covid-19 Vaccination DriveSwarajya StaffApr 19, 2021 09:38 AM
We Need A Dual  Strategy For Covid Vaccine – Market-Based Pricing For Those Who Can Afford It 
We Need A Dual Strategy For Covid Vaccine – Market-Based Pricing For Those Who Can Afford It R JagannathanJan 20, 2021 06:51 AM
Oxford-AstraZeneca Covid-19 Vaccine Approved For Use In UK, Likely To Get Indian Drug Regulator's Nod Soon
Oxford-AstraZeneca Covid-19 Vaccine Approved For Use In UK, Likely To Get Indian Drug Regulator's Nod SoonSwarajya StaffDec 30, 2020 07:33 AM
Covid-19: AstraZeneca, Oxford University Vaccine Shows Up To 90% Effectiveness In Late-Stage Trials 
Covid-19: AstraZeneca, Oxford University Vaccine Shows Up To 90% Effectiveness In Late-Stage Trials Swarajya StaffNov 23, 2020 10:42 AM
ICMR, Serum Institute Complete Enrolment In Phase 3 Clinical Trials For Covid-19 Vaccine 'Covishield'
ICMR, Serum Institute Complete Enrolment In Phase 3 Clinical Trials For Covid-19 Vaccine 'Covishield'Swarajya StaffNov 12, 2020 06:02 AM
Serum Institute To Begin Human Clinical Trials Of Oxford University's Covid-19 Vaccine In India From Today
Serum Institute To Begin Human Clinical Trials Of Oxford University's Covid-19 Vaccine In India From TodaySwarajya StaffAug 25, 2020 07:30 AM
Serum Institute Starts Phase 2, 3 Human Trials Of Oxford-AstraZeneca Covid-19 Vaccine In India
Serum Institute Starts Phase 2, 3 Human Trials Of Oxford-AstraZeneca Covid-19 Vaccine In IndiaSwarajya StaffAug 20, 2020 06:36 AM
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype